Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001019056-25-000184·Autolus Therapeutics plc
Schedule 13G ownership disclosure
AUTOLUS THERAPEUTICS LTD
Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share · CUSIP: 05280R100
Event date: 2025-06-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- MAK Capital Fund LP
Shares: 15,408,638.00 · Class: 5.8%
- MAK Capital One L.L.C.
Shares: 15,408,638.00 · Class: 5.8%
- Michael A. Kaufman
Shares: 15,408,638.00 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-25-000184
- Form type
- SCHEDULE 13G
- Filer
- Autolus Therapeutics plc
- CIK
- CIK 1730463
- Filed
- Jun 25, 2025
- Reporting period
- Jun 17, 2025
- Description
- Schedule 13G beneficial ownership